Key statistics
On Monday, Pacira Biosciences Inc (82P:MUN) closed at 18.32, 8.41% above its 52-week low of 16.90, set on Feb 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 18.32 |
|---|---|
| High | 18.32 |
| Low | 18.32 |
| Bid | 18.00 |
| Offer | 18.30 |
| Previous close | 17.75 |
| Average volume | 130.00 |
|---|---|
| Shares outstanding | 40.49m |
| Free float | 39.89m |
| P/E (TTM) | 139.48 |
| Market cap | 887.13m USD |
| EPS (TTM) | 0.1571 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:04 GMT.
More ▼
- Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)
- Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
- Pacira to Report 2025 Financial Results on Thursday February 26, 2026
- Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
- Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
- Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
- Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
More ▼
